Wednesday, September 25

Tag: Gilead

October was Good and November was Better
News

October was Good and November was Better

On November 1st, twenty-five shares of Gilead Sciences Inc. (GILD) were purchased for $79.29 per share totaling $1,982.25 in stock, and $60.15 in cash was left over (from the sale of the previous month's stock) equaling a grand total of $2,042.60 to start the month. Yesterday November 30th, the 25 shares were sold for $88.02 yielding $2,200.45 in proceeds. Combined with the leftover cash of $60.15, cash totals $2,260.60 heading into December. In August, I started with $2,005 so this trading strategy has returned 12.7 percent in just four months. (adsbygoogle = window.adsbygoogle || []).push({}); For comparison, the S&P 500 exchange-traded index fund, SPY, returned negative 0.2 percent from August through November so our trading strategy continues to...
October was a Good Trading Month
News

October was a Good Trading Month

On October 3rd, five shares of Eli Lilly & Company (LLY) were purchased for $320.69 totaling $1,603.45 in stock, and $295.80 in cash was left over for a grand total of $1,899.25. On November 1st, the shares were sold for $349.37 leaving a grand total of $2,042.60 in cash ($1,746.80 in stock proceeds plus the cash of $295.80). In August, I started with $2,005 so this trading strategy has returned 1.9 percent over the last three months. And LLY is no longer the top stock in the S&P 100 index. (adsbygoogle = window.adsbygoogle || []).push({}); For comparison, the S&P 500 exchange-traded index fund, SPY, returned negative 6.3 percent from August through October so the trading strategy continues to outperform the broader market. While the market w...